| 1 | Profile A | Instantized whey hydrolysate powder | ≥ 90% protein on a dry basis | 15–25% | Predominantly < 2,000 Da | Total plate count, yeast and mold, coliforms, Salmonella and E. coli tested per batch | Lead, arsenic, cadmium and mercury tested against applicable food-safety limits | Batch COA; traceability records; allergen declaration; retained samples |
| 2 | Profile B | Low-lactose whey peptide powder | ≥ 85% protein on a dry basis | 10–20% | Major fraction < 3,000 Da | Routine pathogen screening with documented sampling and laboratory methods | Heavy metals, pesticides and veterinary-drug risks evaluated through risk-based testing | HACCP-based controls; process flow diagram; manufacturing specifications |
| 3 | Profile C | High-solubility whey peptide powder | ≥ 90% protein on a dry basis | 12–22% | At least 80% below 5,000 Da | Release testing for total count, yeast and mold, coliforms and specified pathogens | Contaminant limits defined in the product specification and verified by periodic testing | Supplier approval program; calibration records; deviation and corrective-action procedures |
| 4 | Profile D | Enzymatically hydrolyzed whey protein | ≥ 80% protein on a dry basis | 8–18% | Broad distribution, generally < 10,000 Da | Microbiological limits established according to intended food application | Lead and other regulated metals controlled through raw-material qualification and finished-product testing | Enzyme identity and activity records; allergen cross-contact controls; COA verification |
| 5 | Profile E | Sports-nutrition whey hydrolysate | ≥ 85% protein on a dry basis | 10–25% | Peptide profile confirmed by validated analytical testing | Pathogen absence requirements specified for Salmonella and E. coli | Screening program for prohibited substances and undeclared adulterants where relevant | Product specification; identity testing; lot coding; complaint and recall procedure |
| 6 | Profile F | Whey peptide powder for beverage applications | ≥ 80% protein on a dry basis | 8–16% | Solubility-focused peptide distribution | Routine testing for total aerobic count, yeast, mold and coliforms | Moisture, ash and contaminant limits controlled by approved specifications | Solubility and dispersibility data; packaging validation; storage-stability information |
| 7 | Profile G | Hydrolyzed whey isolate peptide powder | ≥ 90% protein on a dry basis | 15–30% | High proportion of short-chain peptides | Finished-lot microbiological release testing with documented laboratory competence | Heavy-metal results linked to the specific production lot or a justified monitoring plan | Raw-material origin records; change-control system; packaging integrity checks |
| 8 | Profile H | Neutral-flavor whey hydrolyzed peptide | ≥ 85% protein on a dry basis | 10–20% | Particle-size and molecular-weight distribution reported | Microbiological acceptance criteria stated on the COA and product specification | Control of moisture, oxidation indicators and foreign-material risks | Flavor and odor inspection; sensory standards; non-conformance records |
| 9 | Profile I | Rapid-dissolving whey peptide ingredient | ≥ 80% protein on a dry basis | 8–20% | Distribution reported by size-exclusion or equivalent validated method | Pathogen control program appropriate for powdered dairy ingredients | Allergen, melamine and other economically motivated adulteration risks assessed | Validated test methods; laboratory records; environmental-monitoring program |
| 10 | Profile J | Customized whey hydrolysate peptide blend | Specification agreed according to application, commonly ≥ 80% | Customer-defined target range | Customer-defined peptide-size profile | Acceptance criteria agreed before production and verified by lot release | Risk-based testing plan covering metals, pesticides and relevant contaminants | Technical agreement; sample approval; audit access; full batch traceability |